86 related articles for article (PubMed ID: 3314882)
1. Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody.
Volm M; Efferth T; Günther A; Lathan B
Arzneimittelforschung; 1987 Jul; 37(7):862-7. PubMed ID: 3314882
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.
Volm M; Bak M; Efferth T; Lathan B; Mattern J
Anticancer Res; 1988; 8(4):531-5. PubMed ID: 2902821
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Mirski SE; Gerlach JH; Cole SP
Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
[TBL] [Abstract][Full Text] [Related]
4. Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins.
Volm M; Bak M; Efferth T; Mattern J
Anticancer Res; 1988; 8(6):1169-78. PubMed ID: 3218953
[TBL] [Abstract][Full Text] [Related]
5. Immunological detection of Chinese hamster ovary cells expressing a multidrug resistance phenotype.
Lathan B; Edwards DP; Dressler LG; Von Hoff DD; McGuire WL
Cancer Res; 1985 Oct; 45(10):5064-9. PubMed ID: 2862990
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection assays for multidrug resistance.
Efferth T; Volm M
Arzneimittelforschung; 1988 Dec; 38(12):1771-4. PubMed ID: 3245849
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistance phenotype in Chinese hamster ovary cells.
Ling V; Kartner N; Sudo T; Siminovitch L; Riordan JR
Cancer Treat Rep; 1983 Oct; 67(10):869-74. PubMed ID: 6354434
[TBL] [Abstract][Full Text] [Related]
8. Transfer of adriamycin resistance by fusion of Mr 170,000 P-glycoprotein to the plasma membrane of sensitive cells.
Belli JA; Zhang Y; Fritz P
Cancer Res; 1990 Apr; 50(7):2191-7. PubMed ID: 1969329
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
10. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
12. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
[TBL] [Abstract][Full Text] [Related]
13. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.
Hamada H; Okochi E; Oh-hara T; Tsuruo T
Cancer Res; 1988 Jun; 48(11):3173-8. PubMed ID: 3365700
[TBL] [Abstract][Full Text] [Related]
14. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW
Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
16. Evidence for multidrug-resistant cells in human tumor cell populations.
Shoemaker RH; Curt GA; Carney DN
Cancer Treat Rep; 1983 Oct; 67(10):883-8. PubMed ID: 6313186
[TBL] [Abstract][Full Text] [Related]
17. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
Guo H; Lu G; Xiong X; Dong J; Liu S
Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
[TBL] [Abstract][Full Text] [Related]
18. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin).
Ganapathi R; Hercbergs A; Grabowski D; Ford J
Cancer Res; 1993 Jul; 53(14):3262-5. PubMed ID: 8100737
[TBL] [Abstract][Full Text] [Related]
19. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
Pop I; Pop L; Vitetta ES; Ghetie MA
Oncol Rep; 2008 Apr; 19(4):889-95. PubMed ID: 18357372
[TBL] [Abstract][Full Text] [Related]
20. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
Harker WG; Sikic BI
Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
